BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11016625)

  • 1. Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage.
    Chen J
    Cancer Res; 2000 Sep; 60(18):5037-9. PubMed ID: 11016625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
    Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
    Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of phosphatidylinositol 3-kinase-related protein kinases in hyperphosphorylation of replication protein A2 in response to replication-mediated DNA double-strand breaks.
    Sakasai R; Shinohe K; Ichijima Y; Okita N; Shibata A; Asahina K; Teraoka H
    Genes Cells; 2006 Mar; 11(3):237-46. PubMed ID: 16483312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
    Wang HC; Chou WC; Shieh SY; Shen CY
    Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of ATR-interacting protein on Ser239 mediates an interaction with breast-ovarian cancer susceptibility 1 and checkpoint function.
    Venere M; Snyder A; Zgheib O; Halazonetis TD
    Cancer Res; 2007 Jul; 67(13):6100-5. PubMed ID: 17616665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
    Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
    Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies.
    Gatei M; Zhou BB; Hobson K; Scott S; Young D; Khanna KK
    J Biol Chem; 2001 May; 276(20):17276-80. PubMed ID: 11278964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
    Manke IA; Lowery DM; Nguyen A; Yaffe MB
    Science; 2003 Oct; 302(5645):636-9. PubMed ID: 14576432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
    Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
    Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW; Henderson BR
    Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1.
    Park I; Avraham HK
    Exp Cell Res; 2006 Jul; 312(11):1996-2008. PubMed ID: 16630610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.
    Sarkaria JN; Tibbetts RS; Busby EC; Kennedy AP; Hill DE; Abraham RT
    Cancer Res; 1998 Oct; 58(19):4375-82. PubMed ID: 9766667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells.
    Chen YY; Chiang SY; Lin JG; Yang JS; Ma YS; Liao CL; Lai TY; Tang NY; Chung JG
    Anticancer Res; 2010 Mar; 30(3):945-51. PubMed ID: 20393018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.
    Tibbetts RS; Cortez D; Brumbaugh KM; Scully R; Livingston D; Elledge SJ; Abraham RT
    Genes Dev; 2000 Dec; 14(23):2989-3002. PubMed ID: 11114888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.
    Tommiska J; Bartkova J; Heinonen M; Hautala L; Kilpivaara O; Eerola H; Aittomäki K; Hofstetter B; Lukas J; von Smitten K; Blomqvist C; Ristimäki A; Heikkilä P; Bartek J; Nevanlinna H
    Oncogene; 2008 Apr; 27(17):2501-6. PubMed ID: 17982490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response.
    Lee JS; Collins KM; Brown AL; Lee CH; Chung JH
    Nature; 2000 Mar; 404(6774):201-4. PubMed ID: 10724175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53.
    Lakin ND; Hann BC; Jackson SP
    Oncogene; 1999 Jul; 18(27):3989-95. PubMed ID: 10435622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner.
    Tamakawa RA; Fleisig HB; Wong JM
    Cancer Res; 2010 Nov; 70(21):8684-94. PubMed ID: 20837664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein.
    Foray N; Marot D; Gabriel A; Randrianarison V; Carr AM; Perricaudet M; Ashworth A; Jeggo P
    EMBO J; 2003 Jun; 22(11):2860-71. PubMed ID: 12773400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.